France Policy Document

Recommendations for Toxicological Evaluation of Nanoparticle Medicinal Products

2011
Policy Type Regulation
Coverage Level National
Policy Sector Medicine Others
ELSA-HSE Issues Safety

PUBLISHER (s)

  • National Agency for the Safety of Medicines and Health Products